Att 3 - Goals and Objectives

Attachment 3

Goals/Objectives Table

Hepatitis Testing and Linkage to Care (HEPTLC): “Early Identification and Linkage to Care for Persons with Chronic HBC and HCV infections”

Category A: Testing and Referral of Persons who are Chronically Infected with HBV
Goals		Objectives
Increase the proportion of persons among highly affected populations living with chronic HBV infection who are aware of their of their infection: Persons born in countries with intermediate or high rate of HBV infection		Within the project year, conduct approximately 1,000- 4,000 (depending on funding Tier) HBV tests per awardee, to identify chronic HBV-infected persons (Hepatitis B surface antigen and Hepatitis core antibody) who were previously not aware of their infection A minimum of 85% of persons who test positive for hepatitis B receive their test results At least 85% of persons tested for hepatitis B have their risk factors documented including country of birth At least 85% of cases identified during the project period are reported to surveillance within 6 months of diagnosis date
Increase the proportion of persons who tested positive for hepatitis B receive prevention counseling and are linked to care treatment and prevention services		A minimum of 75% of persons who test positive for hepatitis B receive post-test counseling A minimum of 75% of persons who test positive for hepatitis B are linked to care, treatment, and preventive services
Category B: Testing for HCV Infection and Enhancing Linkage to Care for Persons HCV
Goals	Objectives
Increase the proportion of persons among highly-affected populations living with chronic HCV infection who are aware of their of their infection: Persons Who Inject Drugs (PWIDs) and persons who use non-injection opiates Persons born from 1945 through 1965	Within the project year, conduct 1,000 to 4,000 HCV tests per awardee (depending on funding Tier) to identify HCV-infected persons (Hepatitis C antibody and Hepatitis RNA) who were previously not aware of their infection A minimum of 85% of persons who are found to be HCV antibody positive are tested for HCV RNA A minimum of 85% of persons who test positive for HCV RNA receive their test results Obtain risk factor data for at least of 85% of persons tested for hepatitis C antibody At least 85% of cases identified during the project period are reported to surveillance within 6 months of diagnosis date
Increase the proportion of persons who test RNA positive for hepatitis C who receive prevention counseling and are linked to care treatment and prevention services	A minimum of 75% of persons who test positive for HCV RNA receive post-test counseling A minimum of 75% of persons who test positive for hepatitis C RNA are linked to care, treatment, and preventive services A minimum of 15% of persons who test positive for HCV RNA begin antiviral therapy (All CHC settings)
Increase the proportion of newly diagnosed persons who receive antiviral therapy within CHC ECHO settings	A minimum of 50% of physicians and other clinical staff providing care for persons with HCV will participate in training sessions and case presentations At least 100 cases of HCV will be presented in training sessions over the project year Based on the presentation and consultation, at least 75% of persons presented for case conference will have their care management updated including a decision to begin or defer HCV therapy A minimum of 20% of persons presented for case conference will begin antiviral therapy